Abstract
Lipoprotein nanoparticles delivering an inflammation-targeting signalling inhibitor reduce vascular inflammation in atherosclerotic mice.
Original language | English (US) |
---|---|
Pages (from-to) | 269-270 |
Number of pages | 2 |
Journal | Nature Biomedical Engineering |
Volume | 2 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2018 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Medicine (miscellaneous)
- Biomedical Engineering
- Computer Science Applications